Harmony Biosciences Holdings Inc Net Income per Employee (HRMY), current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket
 


Harmony Biosciences Holdings inc   (NASDAQ: HRMY)
 

Harmony Biosciences Holdings Inc Net Income per Employee

HRMY's Quarterly Results, Trends, Rankings, Statistics
Harmony Biosciences Holdings Inc 's Income per employee fell in the third quarter 2026 on a trailing twelve month basis to $ 609,560, but the productivity of Harmony Biosciences Holdings Inc 's 293 employees remained above the company average.
The Healthcare sector has seen employees of 27 other companies achieving higher income per employee. While income per employee total ranking has improved so far to 324, from total ranking in previous quarter at 328.


What is Income per Employee Ratio?






HRMY Net Income per Employee (Sep 30 2026)
III. Quarter
(Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
Y / Y Net Income Change -5.25 % 89.64 % -28.69 % -54.55 % 10.35 %
Net Income per Employee (TTM) $ 609,560 618,669 496,980 541,594 633,706
HRMY's Total Ranking # 324 # 328 # 221 # 65 #
Seq. Net Income Change -36.11 % 132.18 % 44.48 % -55.79 % 27.88 %


HRMY Net Income per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 28
Healthcare Sector # 46
Overall Market # 324

Net Income per Employee Statistics
High Average Low
$ 683,403 $ 420,203 $ 6,515
(Jun 30 2023)   (Sep 30 2020)







Companies with similar Income per Employee for 12 month ending Sep 30 2026, within Healthcare Sector Income per Employee Income 12 month ending Sep 30 2026Number of Employees Sep 30 2026
Nurix Therapeutics Inc   930,211.36 $ 294.877  Million 317 
Krystal Biotech Inc   763,281.36 $ 225.168  Million 295 
Illumina Inc   699,218.75 $ 895.000  Million 1,280 
Black Hawk Acquisition Corporation  649,852.50 $ 1.300  Million 2 
Eli Lilly And Company  551,594.00 $ 27,579.700  Million 50,000 
Indivior Pharmaceuticals Inc   451,000.00 $ 451.000  Million 1,000 
Denali Therapeutics Inc   393,667.99 $ 198.015  Million 503 
Neurocrine Biosciences Inc   351,250.00 $ 702.500  Million 2,000 
Standard Biotools Inc   342,097.69 $ 133.076  Million 389 
Regeneron Pharmaceuticals Inc   312,615.18 $ 4,817.400  Million 15,410 


Date modified: 2026-11-05T10:38:16+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.